Summary & Overview
HCPCS G8724: Missing Pathology pN Category and Histologic Grade
HCPCS Level II code G8724 denotes that a pathology report lacks documentation of patient category, pN (pathologic nodal) category, and histologic grade without an explanatory reason. Nationally, this code is used to identify gaps in pathology reporting that can affect cancer staging, treatment planning, quality measurement, and registry completeness. Its use matters for providers, payers, and registries focused on oncology care coordination and quality metrics. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what G8724 represents, why missing pathology elements are significant for clinical and administrative processes, and what benchmarks and policy implications commonly accompany its reporting. The publication provides clinical context on the documentation elements flagged by the code, summarizes how major payers and Medicare approach reporting and adjudication when pathology details are absent, and outlines typical service settings where G8724 is applied. Data limitations: where specific taxonomies, ICD-10 mappings, and related procedure codes are not provided, the text notes “Data not available in the input.”
Billing Code Overview
HCPCS Level II code G8724 indicates that patient category, pathologic nodal (pn) category, and histologic grade were not documented in the pathology report, reason not given. This code is used to flag missing structured pathology staging details that are typically relevant for oncology care and cancer registry reporting.
Service type: Pathology / Diagnostic Reporting Review
Typical site of service: Hospital outpatient pathology department or independent pathology laboratory
Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 62-year-old female undergoes surgical resection of a breast mass. The specimen is sent to pathology for tumor staging and reporting. The pathology report documents invasive carcinoma but omits the patient category (e.g., primary vs. metastatic), pathologic node (pN) category, and histologic grade without providing a reason. Surgical and oncology teams rely on the pathology report to determine adjuvant therapy and staging for treatment planning and cancer registry abstraction. The typical workflow: surgeon submits specimen with clinical history and requisition; pathologist performs grossing, microscopy, and ancillary testing (immunohistochemistry); pathologist issues a final report that should include tumor site, size, margins, pT and pN categories, and histologic grade. When pN and grade are missing, clinicians may request an amended report or supplemental testing (deeper levels, additional stains) before final treatment decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when reporting unusually extensive pathology evaluation beyond typical effort (e.g., multiple additional levels or complex ancillary studies) documented in the report. |
23 | Unusual anesthesia |